US Bancorp
IBDQ

US Bancorp’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

US Bancorp’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-650,307
Closed -$16.4M – 4122
2025
Q3 		$16.4M Sell
650,307
-235,274
-27% -$5.91M 0.02% 355
2025
Q2 		$22.3M Sell
885,581
-63,508
-7% -$1.6M 0.03% 304
2025
Q1 		$23.9M Sell
949,089
-282,495
-23% -$7.09M 0.03% 289
2024
Q4 		$30.9M Sell
1,231,584
-81,086
-6% -$2.03M 0.04% 252
2024
Q3 		$32.9M Sell
1,312,670
-17,562
-1% -$438K 0.04% 249
2024
Q2 		$33.1M Sell
1,330,232
-10,082
-0.8% -$250K 0.05% 231
2024
Q1 		$33.3M Buy
1,340,314
+53,739
+4% +$1.33M 0.05% 234
2023
Q4 		$31.9M Buy
1,286,575
+3,297
+0.3% +$80.8K 0.05% 234
2023
Q3 		$31.3M Sell
1,283,278
-100,949
-7% -$2.46M 0.05% 224
2023
Q2 		$33.7M Buy
1,384,227
+16,108
+1% +$394K 0.05% 219
2023
Q1 		$33.6M Sell
1,368,119
-3,251
-0.2% -$79.4K 0.06% 216
2022
Q4 		$33.4M Sell
1,371,370
-48,901
-3% -$1.18M 0.06% 212
2022
Q3 		$34.3M Buy
1,420,271
+59,075
+4% +$1.46M 0.07% 188
2022
Q2 		$33.6M Buy
1,361,196
+133,679
+11% +$3.33M 0.07% 199
2022
Q1 		$31M Buy
1,227,517
+134,582
+12% +$3.47M 0.05% 223
2021
Q4 		$28.9M Buy
1,092,935
+143,981
+15% +$3.83M 0.05% 239
2021
Q3 		$25.5M Buy
948,954
+15,640
+2% +$422K 0.05% 245
2021
Q2 		$25.2M Buy
933,314
+150,306
+19% +$4.06M 0.05% 254
2021
Q1 		$21M Buy
783,008
+84,188
+12% +$2.28M 0.04% 272
2020
Q4 		$19.1M Buy
698,820
+187,441
+37% +$5.1M 0.04% 282
2020
Q3 		$13.9M Buy
511,379
+187,463
+58% +$5.09M 0.03% 311
2020
Q2 		$8.74M Buy
323,916
+120,230
+59% +$3.16M 0.02% 376
2020
Q1 		$5.09M Buy
203,686
+16,442
+9% +$424K 0.02% 437
2019
Q4 		$4.86M Buy
187,244
+18,553
+11% +$480K 0.01% 521
2019
Q3 		$4.37M Buy
168,691
+14,741
+10% +$379K 0.01% 537
2019
Q2 		$3.94M Buy
153,950
+5,168
+3% +$129K 0.01% 571
2019
Q1 		$3.7M Buy
148,782
+6,192
+4% +$151K 0.01% 565
2018
Q4 		$3.37M Buy
142,590
+3,065
+2% +$72.5K 0.01% 564
2018
Q3 		$3.34M Sell
139,525
-630
-0.4% -$15.1K 0.01% 627
2018
Q2 		$3.35M Buy
140,155
+16,680
+14% +$399K 0.01% 613
2018
Q1 		$3M Buy
123,475
+14,462
+13% +$353K 0.01% 651
2017
Q4 		$2.73M Buy
109,013
+13,993
+15% +$351K 0.01% 680
2017
Q3 		$2.39M Buy
95,020
+22,319
+31% +$561K 0.01% 727
2017
Q2 		$1.82M Buy
72,701
+18,885
+35% +$471K 0.01% 806
2017
Q1 		$1.33M Buy
53,816
+12,549
+30% +$308K ﹤0.01% 946
2016
Q4 		$1M Buy
41,267
+22,607
+121% +$562K ﹤0.01% 1064
2016
Q3 		$478K Buy
18,660
+15,176
+436% +$389K ﹤0.01% 1358
2016
Q2 		$89K Buy
+3,484
New +$87.4K ﹤0.01% 2110

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

US Bancorp's IBDQ Position: Q4 2025 in Review

US Bancorp sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 650,307 shares — an estimated $16.4M sold.

US Bancorp first reported a position in IBDQ in Q2 2016 and held it in 38 quarters. The position peaked at $34.3M in Q3 2022. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • US Bancorp reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • US Bancorp sold 650,307 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $16.4M.
  • US Bancorp first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2016 and held it in 38 quarters.
  • US Bancorp's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $34.3M in Q3 2022.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on US Bancorp's 13F filing for Q4 2025, filed 30 Jan 2026.